The Research Triangle Is a Top-Five

Global Life Sciences Hub  and Accelerating

Biogen, J&J, Novo Nordisk, Fujifilm, Amgen are all investing billions in our backyard.

2025–2026 Snapshot
100K+

Life sciences jobs in North Carolina — crossed this threshold for the first time in 2023 and growing

 $7B+

Recent RTP area investment announcements: Biogen $2B, J&J $2B+, Fujifilm + Amgen $3.2B in Holly Springs

 15×

Growth in digital health VC deals in RTP — from $4M in 2024 to $60M in 2025 (Rock Health data)

Indian-origin scientists and physicians are disproportionately represented in Triangle life sciences leadership at Biogen, GSK, Novo Nordisk, Duke Medicine, and UNC Health. Indic Leadership Forum can serve as the convening body for this community — connecting researchers with biotech entrepreneurs, MedTech investors, and the broader diaspora capital network in a way no other organization in NC currently does.

The Moment We're In

The Research Triangle is no longer an emerging biotech cluster — it is a mature, globally competitive hub. At the intersection of AI and genomics, NC-based companies and university labs are deploying machine learning to accelerate drug discovery, identify biomarkers, and personalize treatment protocols. Genentech doubled its Holly Springs investment to $2B. Johnson & Johnson is building a second Wilson County manufacturing facility. Fujifilm Biotechnologies cut the ribbon on a new Holly Springs facility. The capital stack from seed to growth is finally complete, with Hatteras Venture Partners, Cape Fear BioCapital, and Alexandria Seed Capital all active in the region.

  • →NIH grant funding has declined in recent years — including from DOGE-related cuts in 2025. How do Triangle researchers and startups adapt their funding strategies?

  • →FDA regulatory strategy for AI/ML in clinical decision support (SaMD pathways) — what do Triangle health-tech founders need to know before they build?

  • →The talent pipeline challenge: as biomanufacturing scales, NC faces a skilled workforce gap. Community college partnerships and reskilling programs as strategic leverage.

Focus areas

Genomics + AI

Active

Large language models trained on genomic data. AI-driven biomarker discovery. Duke-affiliated Ten63 Therapeutics using AI for drug discovery. The convergence of bioinformatics and foundation models.

Digital health & health-tech

Remote patient monitoring, AI-powered diagnostics, FDA SaMD regulatory pathways. RTP startups pitching at Triangle Venture Day 2025 — Indic Leadership Forum as the convening and amplification platform.

Biomanufacturing

NC's eastern region emerging as a biomanufacturing powerhouse. Cell & gene therapy, mRNA platforms, oligonucleotides, antibody-drug conjugates — the advanced modalities driving facility investment in RTP.

Healthcare AI governance

FDA regulatory strategy for AI/ML clinical tools. Data sovereignty and interoperability. The ethics and accountability frameworks for AI-driven clinical recommendations in hospital systems.